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Abstract
Background: A useful application of flow cytometry is the investigation of cell receptor-ligand
interactions. However such analyses are often compromised due to problems interpreting changes
in ligand binding where the receptor expression is not constant. Commonly, problems are
encountered due to cell treatments resulting in altered receptor expression levels, or when cell
lines expressing a transfected receptor with variable expression are being compared. To overcome
this limitation we have developed a Microsoft Excel spreadsheet that aims to automatically and
effectively simplify flow cytometric data and perform statistical tests in order to provide a clearer
graphical representation of results.
Results: To demonstrate the use and advantages of this new spreadsheet method we have
investigated the binding of the transmembrane adhesion receptor CD44 to its ligand hyaluronan.
In the first example, phorbol ester treatment of cells results in both increased CD44 expression
and increased hyaluronan binding. By applying the spreadsheet method we effectively demonstrate
that this increased ligand binding results from receptor activation. In the second example we have
compared AKR1 cells transfected either with wild type CD44 (WT CD44) or a mutant with a
truncated cytoplasmic domain (CD44-T). These two populations do not have equivalent receptor
expression levels but by using the spreadsheet method hyaluronan binding could be compared
without the need to generate single cell clones or FACS sorting the cells for matching CD44
expression. By this method it was demonstrated that hyaluronan binding requires a threshold
expression of CD44 and that this threshold is higher for CD44-T. However, at high CD44-T
expression, binding was equivalent to WT CD44 indicating that the cytoplasmic domain has a role
in presenting the receptor at the cell surface in a form required for efficient hyaluronan binding
rather than modulating receptor activity.
Conclusion: Using the attached spreadsheets and instructions, a simple post-acquisition method
for analysing bivariate flow cytometry data is provided. This method constitutes a straightforward
improvement over the standard graphical output of flow cytometric data and has the significant
advantage that ligand binding can be compared between cell populations irrespective of receptor
expression levels.
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Background
The investigation of receptor-ligand interactions by flow
cytometry is a technique commonly employed in immu-
nology and cell biology primarily due to the ability to rap-
idly analyse populations of cells. This, however, results in
the generation of large data sets, the further analysis of
which is inherently problematic. With existing software,
alterations in ligand binding in response to stimuli or as a
result of receptor manipulation are difficult to dissect. Par-
ticularly problematic is the comparison of different trans-
fected cell populations, which frequently have variable
protein expression, or when treatment of cells causes a
shift in receptor expression. To date two main approaches
have been taken to overcome these issues. First, different
populations of cells can be matched for receptor expres-
sion levels either by fluorescence activated cell sorting
(FACS) (e.g. [1]) or by selecting single cell clones (e.g.
[2]). The main disadvantage of this approach is that
expression levels in the different populations/clones have
to be constantly monitored. This can become costly in
terms of FACS usage, tissue culture expenses and time, and
impractical when dealing with multiple transfectants
especially if multiple clones for each transfectant have to
be maintained. The second approach has been to post-
analyse flow cytometric data. For this, a series of cell sub-
populations are assigned based on the level of receptor
expression to a set of fluorescence channel ranges (e.g.
[3,4]). The corresponding mean fluorescence intensity for
ligand binding is then calculated allowing the data set to
be presented as a line graph of receptor expression versus
ligand binding. This method has the advantage of allow-
ing receptor:ligand interactions to be studied over a wide
range of receptor expression levels.
Consequently, binding of ligand to different transfected
cell populations can be compared. The main problem is
that the method of data analysis is entirely manual and
therefore dividing the population into a large series of
data points becomes unmanageable. Building upon this
concept, we have developed an automated spreadsheet-
based method to post-analyse flow cytometry data. Using
commonly available computer software, this spreadsheet
enables the analysis of two-colour flow cytometric data by
calculating the average fluorescence intensity value of the
variable parameter for all cells lying within a single fluo-
rescence channel of a constant parameter. This provides
the correlation of data at the highest level of accuracy. To
demonstrate the use and advantages of this new method,
two worked examples of the interaction of the adhesion
receptor CD44 with its ligand hyaluronan are reported
here.
Results and discussion
CD44 is a transmembrane adhesion receptor and part of
the hyaladherin protein family whose common ligand is
the extracellular glycosaminoglycan hyaluronan [5,6].
Two-colour flow cytometry has been widely used to char-
acterise this receptor-ligand interaction using fluorescein
isothiocyanate (FITC) conjugated hyaluronan and anti-
CD44 antibodies, either directly conjugated or detected
with a second layer antibody. By this approach, the bind-
ing capacity of CD44 mutants or the activation of hyaluro-
nan-binding activity following various treatments has
been investigated. However, as FITC-hyaluronan binding
is strictly dependent on CD44 expression levels, the anal-
ysis is compromised where expression levels are not
matched. As described in the background, two main
approaches have been taken to overcome this problem.
Cells have been FACS sorted or single cell cloned to gen-
erate starting populations with equivalent levels of CD44
expression [1,2]. Alternatively flow cytometry data has
been analysed manually to assess levels of hyaluronan
binding relative to receptor expression [3,4]. The follow-
ing examples demonstrate how the spreadsheet method
can be used to overcome these problems.
Example 1: Monitoring receptor:ligand interactions after 
cellular treatment
The mouse T-cell lymphoma cell line BW5147 expresses
CD44 and constitutively binds hyaluronan. This binding
is known to be increased by long-term phorbol myristate
acetate (PMA) treatment [7]. However it has been difficult
to determine whether this increase in hyaluronan binding
results from an increased binding activity of CD44, that is
receptor activation, or increased CD44 expression. To
assess whether the spreadsheet method could resolve this
issue the following experiment was undertaken.
BW5147 cells were left untreated or treated with 100 ng/
ml PMA for 1 h (short-term treatment) or 48 h (long-term
treatment). The cells were incubated with FITC-hyaluro-
nan followed by biotinylated anti-CD44 mAb IM7 and
PE-streptavidin. Cells were then stained with membrane
impermeable DNA binding dye TO-PRO-3 and subjected
to three-colour flow cytometry. TO-PRO-3 is a widely
used viability dye and only cells which exhibited low TO-
PRO-3 fluorescence were used in the analysis. Histogram
analysis of the data (Fig. 1A) or displaying the data as two
dimensional dot-plots (Fig. 1B) shows that CD44 levels
and FITC-hyaluronan binding increased after 48 h PMA
treatment but not after 1 h treatment.
The flow cytometry data was exported and analysed using
the spreadsheet method as described in the Methods sec-
tion. Briefly, the mean FITC-hyaluronan fluorescence
intensity was calculated for each of the 1024 PE-CD44
channels and the resulting points were plotted (Fig. 1C).
It was empirically determined that more than 4 cells were
required to provide an adequate average fluorescence
intensity value for any particular channel and thereforeBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/10
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Analysis using the spreadsheet method of the effects of PMA treatment on hyaluronan binding to CD44 Figure 1
Analysis using the spreadsheet method of the effects of PMA treatment on hyaluronan binding to CD44 
BW5147 cells were left untreated or treated with 160 nM PMA for 1 h or 48 h and then stained for three-colour flow cytom-
etry as described in the Methods. For the negative control, untreated cells were stained with FITC-BSA followed by PE-
streptavidin. The flow cytometry data is displayed as follows: A, histogram plots showing CD44 expression or FITC-hyaluro-
nan binding for each treatment. B, two-parameter dot plots correlating FITC-hyaluronan binding against CD44 expression. C, 
the data was analysed using the spreadsheet method (see text for further details). The values given are arbitrary fluorescence 
units. Where there were 3 cells or fewer for a given PE fluorescence channel, the point is plotted at 0 on the y-axis.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/10
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channels with 3 cells or fewer were rejected from the anal-
ysis and are shown as a 0 value on the y axis. The plots
clearly demonstrate that across the entire range of CD44
expression, no appreciable differences were observed
between untreated and 1 h PMA treated cells. In contrast,
long term PMA treatment results in increased FITC-
hyaluronan binding relative to untreated cells at all CD44
expression levels. Therefore it can be concluded that long-
term PMA treatment results in an activation of CD44
which enhances its binding capacity.
Given that this increased receptor activity is only observed
after long-term PMA treatment it is likely that this reflects
the induction by PMA of a newly synthesised modified
CD44 population with altered binding properties. To
date, the best characterized post-translational modifica-
tion of CD44 which might result in altered ligand binding
is a change in receptor glycosylation [8].
Example 2: Comparing receptor:ligand interactions in two 
transfected cell populations
The CD44 negative murine T-lymphoma cell line AKR1
has commonly been used as a transfection model to study
CD44 function [9]. Expression of human or mouse wild
type CD44 (WT CD44) in these cells confers to them the
ability to bind hyaluronan [1,4]. In these studies it was
demonstrated that FITC-hyaluronan binding is dependent
on the level of CD44 expression and is typically only seen
after a threshold level of CD44 expression is reached.
These studies also reported that CD44 mutants in which
the cytoplasmic domain has been removed (CD44-T)
have a hyaluronan binding defect; although this mutant
receptor binds hyaluronan, the threshold expression level
required for hyaluronan binding is greater than that
observed for WT CD44. Here we have investigated
whether the spreadsheet method can be used to compare
the hyaluronan binding capacity of two CD44 constructs
with unmatched expression levels without the need to
generate matched populations by FACS sorting or single
cell cloning.
AKR1 cells were stably transfected with human WT CD44
or CD44-T and were subjected to the FITC-HA binding
assay as described in Fig. 1, except that CD44 expression
levels were monitored using the mouse anti-human CD44
mAb E1/2 followed by anti-mouse PE-F(ab)2. Histogram
analysis of data (Fig. 2A) shows that although total popu-
lations of both transfectants have a similar mean CD44
fluorescence intensity (geometric mean 249 and 253 arbi-
trary units for WT CD44 and CD44-T respectively), the
CD44-T cells display a much wider receptor expression
range. The corresponding FITC-hyaluronan binding histo-
grams show that the majority of CD44-T transfected cells
exhibit little ligand binding above control levels. The
remaining cells, however, have a broad binding profile
that overlaps and extends beyond the maximum FITC-
hyaluronan binding by WT CD44. Examining the two
dimensional dot-plots (Fig. 2B) indicates that a FITC-
hyaluronan binding threshold exists for both WT CD44
and CD44-T and that this threshold is possibly higher for
CD44-T. However, the complexity of these profiles does
not permit any accurate conclusions to be drawn from this
data and highlights the deficiencies in comparisons
between the two cell populations using traditional graph-
ical outputs.
Using the spreadsheet, the average hyaluronan binding
for cells lying in each PE-CD44 channel is calculated, pro-
viding visually simplified dot plots presented as overlays.
The plots generated by the spreadsheet clearly demon-
strate that the threshold level of hyaluronan binding by
WT CD44 is reached at approximately 450 fluorescence
units while the threshold for the CD44-T transfected cells
is reached at approximately 600 fluorescence units. How-
ever, once this threshold has been reached, the CD44-T
highest expressing cells reach binding levels similar to
those of WT CD44.
In addition, a Student's t-test can be applied to the data to
identify regions of the plot where FITC-hyaluronan bind-
ing is significantly different between WT and mutant
CD44. This statistic is only calculated for CD44 channels
where 4 cells or more are counted for both cell lines. If the
FITC-hyaluronan binding between two cell lines counted
in a particular CD44 channel is found be significantly dif-
ferent at the 99.9% level, a point is plotted at position 980
on the y-axis for that particular channel. If there is no sig-
nificant difference, a point is not plotted (see Fig. 2C).
Using this analysis, the region between 450 and 800 fluo-
rescence units displays the most robust area of statistical
significance.
This second example illustrates the problems of compar-
ing ligand binding in two cell populations transfected
with different receptor constructs. In the case of hyaluro-
nan binding by WT CD44 and CD44-T, the problem is
acute as it is difficult to achieve transfected populations
with similar expression profiles possibly because the
CD44-T mutant has a significantly reduced half-life com-
pared to WT CD44 [10]. With the spreadsheet method a
direct comparison has been made between these two non-
identical transfected populations. The demonstration that
CD44-T can bind hyaluronan with high efficiency pro-
vided it is expressed at sufficiently high levels provides
important clues as to how ligand binding by CD44 might
be regulated. One explanation for the data presented here
is that CD44 needs to be stabilised at the plasma mem-
brane, for example by clustering or association with the
cytoskeleton, and that this is only achieved at threshold
levels of receptor expression [11]. The higher threshold ofBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/10
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Use of the spreadsheet method incorporating students' t-test analysis to examine hyaluronan binding function of wild type and  mutant CD44 receptors expressed in AKR1 cells Figure 2
Use of the spreadsheet method incorporating students' t-test analysis to examine hyaluronan binding function 
of wild type and mutant CD44 receptors expressed in AKR1 cells AKR1 cells transfected with WT CD44 or CD44-T 
were stained for three-colour flow cytometry as described in the Methods. For the negative control, WT CD44 expressing 
cells were stained with FITC-BSA and rabbit anti-mouse PE-F(ab)2. The flow cytometry data is displayed as follows: A, histo-
gram plots showing CD44 expression or FITC-hyaluronan binding. B, two-parameter dot plots correlating FITC-hyaluronan 
binding against CD44 expression. C, the data was analysed using the spreadsheet method (see text for further details). Where 
there were 3 cells or fewer for a given PE fluorescence channel, the point is plotted at 0 on the y-axis. Values are arbitrary flu-
orescence units. Analysis used the spreadsheet method including application of a students' t-test. Where there was a significant 
statistical difference in FITC-hyaluronan binding between WT CD44 and CD44-T at the 99.9% level, a point is plotted at 980 
on the y-axis.
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CD44-T expression required for ligand binding may
reflect a requirement for the cytoplasmic domain in stabil-
ising the receptor at the cell surface but that this require-
ment can be overcome if sufficiently high levels of the
mutant receptor are expressed due to the enforced close
proximity of receptors.
Conclusions
The spreadsheet method demonstrated here is applied to
the problem of CD44-hyaluronan binding but is also gen-
erally applicable to the study of other receptor-ligand
interactions or where two dependent parameters are being
compared using flow cytometry. The large data sets
acquired by flow cytometry are intrinsically complex and
problematic to analyse. Previous workers have attempted
to mathematically model flow cytometric curves of cell
populations [12] but the complex nature of these curves
has been a barrier to further analysis. Roederer and col-
leagues [13] developed a test they have termed 'probabil-
ity binning analysis' to determine whether a test
distribution of flow cytometry data is different from a con-
trol distribution. This was done by dividing data into a
series of bins each containing an equal number of cells
and applying a variant of the chi-squared statistic. This
method estimates the probability that the two distribu-
tions are significantly different and although powerful,
this approach is relatively difficult to implement. The
spreadsheet method provides a considerable advantage
over previous techniques in that it utilises commonly
available programs to simplify flow cytometric data. This
constitutes a straightforward improvement upon the
standard form of graphical output of flow cytometric data
generating a representation of areas of statistical signifi-
cance. In addition, this method provides the first step for
further manipulation of the data, for example to calculate
affinity constants or to perform more complex statistical
analyses, using advanced mathematical packages.
Methods
Cell lines and flow cytometry
The mouse T-cell lymphoma cell lines BW5147 and AKR1
were maintained as previously described [9,10]. Popula-
tions of AKR1 cells transfected with WT CD44 and the
cytoplasmic tail truncation mutant CD44-T constructs in
the pSRα eukaryotic expression vector were established
and selected as previously described [1].
For binding assays, 2 × 106 cells were washed twice, incu-
bated for 1 h with 250 microlitres of 10 micrograms/ml
FITC-hyaluronan at 37°C before washing twice more. All
dilutions and washes were done in Hanks Balanced Salts
Solution (HBSS; Life Technologies) supplemented with
1% foetal calf serum (FCS; Life Technologies). In some
experiments, FITC-bovine serum albumin (Molecular
Probes) was used at 10 micrograms/ml as a negative con-
trol. BW5147 cells were subsequently stained with 1
micrograms/ml biotinylated anti-CD44 mAb IM7 (Caltag
Medsystems) followed by 0.5 micrograms/ml PE-strepta-
vidin (Pharmingen, Becton-Dickinson) and AKR1 cells
stained with 1 microgram/ml anti-CD44 mAb E1/2 fol-
lowed by 25 micrograms/ml PE-conjugated rabbit anti-
mouse Ig F(ab)2 (DAKO Cytomation). Cells were washed
twice and resuspended in 0.3 micromolar TO-PRO-3
(Molecular Probes) diluted in phosphate buffered saline.
A Becton-Dickinson FACSCalibur analyser running Cel-
lQuest V3.2 software (Becton-Dickinson) was used to
read cell fluorescence values. The population of cells with
low TO-PRO-3 fluorescence was selected and the phyco-
erythrin (PE)-CD44 and FITC-hyaluronan fluorescence
values of 60,000 cells were read.
Data was collected with compensation adjusted for FITC
(FL-1 = FL-1 – 0.3% FL-2) and PE (FL-2 = FL-2 – 27% FL-
1). In our application, we have found that compensation
settings have little overall effect on the data provided that
the flow cytometer photomultiplier (PMT) voltages are set
up so that fluorescence is detected well within the availa-
ble range (data not shown). This minimises the chance of
compensation moving data into an area where the
detection range becomes non-linear (usually at the bor-
ders of detection) or even outside detection thus giving a
skewed result. However, it is strongly suggested that the
use of alternative fluorochromes or different instrumenta-
tion will require optimisation of the compensation levels.
Analysis of data using the spreadsheet method
Formulae used in the spreadsheet calculation are listed in
Table 1. The first step in the analysis sequence is to locate
all cells with identical fluorescence channel values for
CD44 and average their corresponding FITC-HA fluores-
cence channel values (formula A). This incorporates for-
mula B where if 3 cells or fewer are found with a particular
CD44 value the value "x" is returned, the average is not
calculated and a point is plotted at position 0 on the y-axis
of the dot plot. If two cell lines or treatments are being
compared then a paired Students t-test can be performed.
The standard deviation and variance of averaged data (for-
mulas C and D, respectively) are first calculated followed
by the confidence interval, which is calculated using the
Excel function (formula E). The t-test is performed when-
ever the spreadsheet detects valid data resulting from for-
mula A (i.e. more than 4 cells of a particular fluorescent
intensity are present and an average value has been calcu-
lated) in both cell lines or treatments (formula F). The cal-
culation for degrees of freedom is shown in formula G
and critical t-values for a range of degrees of freedom are
generated using an Excel function (formula H). These are
then compared to the calculated t-values from formula F
and a point plotted in the chart for significance at the
99.9% level (formula I) at position 980 on the y-axis andBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/10
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using the channel value as the x-axis coordinate. If the cal-
culated t-value is greater than the corresponding critical t-
value then the null hypothesis that the two fluorescence
readings are the same is accepted and a point is not
plotted.
Instructions for use
Data was extracted from the Becton-Dickinson format
using the program FCS Assistant version 1.1 http://
www.fcspress.com ( ©R. Hicks, UK) although other pro-
grams which are capable of extracting raw data from flow
cytometry files (for example WinList (Verity Software
House, ME, USA) or FlowJo (Tree Star Inc. CA, USA)) can
also be used. Each CellQuest data file to be analysed was
opened in FCS Assistant and flow cytometric data
exported as raw tabular text from the FILE menu. The
resulting raw tabular text files (*.rtt) were opened in
Microsoft Excel and the appropriate FL columns for the
"Constant" and "Variable" values were selected, copied
and pasted into the corresponding calculation sheet col-
umns. The "Constant" column (FL-2/CD44) corresponds
to the x-axis coordinate and the "Variable" column (FL-1/
FITC-hyaluronan) corresponds to the y-axis coordinate.
The data transfer was repeated for each cell line or treat-
ment to be analysed. A macro was prepared to start
spreadsheet calculations in Microsoft Excel spreadsheet
calculation was initiated by pressing the "Calculate
spreadsheet" button in the "DATA" sheet window of the
workbook. Spreadsheet files have been prepared and
tested on Windows 2000/XP using Microsoft Office 2000
Professional and on Apple Macintosh OS 9.2 using Micro-
soft Office 2001. The graphical output is automatically
generated in the "Chart" worksheet.
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